Christopher A. Slapak

An Increase in the Expression of Ribonucleotide Reductase Large Subunit 1 Is Associated with Gemcitabine Resistance in Non-Small Cell Lung Cancer Cell Lines

Jennifer D. Davidson, Liandong Ma, Michael Flagella et al. · Cancer Research · 2004 · 282 citations

Medicine, Oncology, Pharmacology +14

Phase II Study of Enzastaurin, a Protein Kinase C Beta Inhibitor, in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Michael J. Robertson, Brad S. Kahl, Julie M. Vose et al. · Journal of Clinical Oncology · 2007 · 231 citations

Medicine, Oncology, Pharmacology +15

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

Alan Sandler, Michael A. Gordon, Dinesh P. de Alwis et al. · Clinical Cancer Research · 2004 · 151 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Vesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes

Selwyn J. Hurwitz, Masanori Terashima, Nobuyuki Mizunuma et al. · Blood · 1997 · 136 citations · Full text

Life Sciences, Cell Biology, Oncology +14

Abrogation of Mitochondrial Cytochrome c Release and Caspase-3 Activation in Acquired Multidrug Resistance

Hiromi Kojima, Kazuya Endo, Hiroshi Moriyama et al. · Journal of Biological Chemistry · 1998 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17